# Final GO/NO-GO after remediation

Дата: 2026-07-29.

| Scenario | Verdict | Evidence | Blocker/condition |
|---|---|---|---|
| Local no-model UI/demo | GO | fail-closed readiness, UI и safety contract verified | Не показывать mock как model result |
| Local mocked API testing | GO | 163 tests; 98.11% branch coverage | Только software contract |
| Public non-clinical API | NO-GO | approved model отсутствует; quota per-process | Model release + gateway/global quota + deployment verification |
| Research single-cell use | CONDITIONAL GO | QC/manifest/contracts реализованы | Approved model, protocol, model card; no clinical claim |
| Research slide summary | CONDITIONAL GO | Wilson/counting implementation verified | Только pre-cropped cells; sampling/model error disclosed |
| Retrospective clinical research | INSUFFICIENT EVIDENCE | model/cohort отсутствуют | Ethics, data lineage, reference standard, locked SAP |
| Prospective silent evaluation | INSUFFICIENT EVIDENCE | G0–G2 FAIL | Сначала retrospective external validation |
| Clinical decision support | NO-GO | G0/G1/G2 FAIL, G3 PARTIAL | External/prospective evidence, QMS, human workflow |
| Autonomous diagnosis | NO-GO | вне intended scope | Не является разрешённой product strategy |

Quality Score: **51.02/100**. Цель 95/100 не достигнута и не заявлена:
clinical/model evidence, data governance и external validation отсутствуют.
Coverage: **98.11%** при обязательном gate `fail_under=95`.
